Skip to main content
Top
Published in: The European Journal of Health Economics 3/2015

01-04-2015 | Original Paper

Transforming EQ-5D utilities for use in cost–value analysis of health programs

Authors: Erik Nord, Rune Johansen

Published in: The European Journal of Health Economics | Issue 3/2015

Login to get access

Abstract

In a number of jurisdictions there is increasing interest in incorporating concerns for fairness in models for economic evaluation of health interventions. Cost–value analysis is a name for evaluations with such a broader aim. The most widely held concern for fairness is a concern for the worse off, i.e. the idea that severity of illness should count in determining priorities. In economic evaluations of improvements in health-related quality of life this concern may be taken into account by replacing conventional health state utilities with societal values for health states that are characterised by strong upper end compression and decreasing marginal value of utility gains. We review evidence on the strength of concerns for the worse off—measured at the cardinal level—in 15 articles published in peer-reviewed journals in the time period 1978–2010, with reports from altogether 20 individual studies in nine different countries. We report 116 individual observations of paired comparisons of utility improvements with different start levels. Concerns for severity show up quite strongly across countries, sample types and question framings. By means of regression analyses we fit a societal value function to the data that has the property of decreasing marginal value of utility gains. Using the central tendency in the data we present two plausible transformations of EQ-5D utilities into societal values that reflect concerns for the worse off.
Appendix
Available only for authorised users
Literature
1.
go back to reference Drummond, M., Brixner, D., Gold, M., Kind, P., McGuire, A., Nord, E.: Toward a consensus on the QALY. Value Health 12(Supplement 1), S31–S35 (2009)CrossRefPubMed Drummond, M., Brixner, D., Gold, M., Kind, P., McGuire, A., Nord, E.: Toward a consensus on the QALY. Value Health 12(Supplement 1), S31–S35 (2009)CrossRefPubMed
2.
go back to reference Norwegian Commission for Prioritising in Health Care. Retningslinjer for prioritering innen helsevesenet. (Guidelines for prioritising in health care). NOU 1987:23. Oslo: Universitetsforlaget (1987) Norwegian Commission for Prioritising in Health Care. Retningslinjer for prioritering innen helsevesenet. (Guidelines for prioritising in health care). NOU 1987:23. Oslo: Universitetsforlaget (1987)
3.
go back to reference Dutch Government Committee on Choices in Health Care: Choices in health care. Ministry of Welfare, Health and Cultural Affairs, Rijswijk (1992) Dutch Government Committee on Choices in Health Care: Choices in health care. Ministry of Welfare, Health and Cultural Affairs, Rijswijk (1992)
4.
go back to reference Swedish Health Care and Medical Priorities Commission. No easy choices. SOU 1993:93. Stockholm: Ministry of Health and Social Affairs (1993) Swedish Health Care and Medical Priorities Commission. No easy choices. SOU 1993:93. Stockholm: Ministry of Health and Social Affairs (1993)
5.
go back to reference Campbell, A., Gillett, G.: Justice and the right to health care. In Ethical Issues in Defining Core Services. Wellington: The National Advisory Committee on Core Health and Disability Support Services (1993) Campbell, A., Gillett, G.: Justice and the right to health care. In Ethical Issues in Defining Core Services. Wellington: The National Advisory Committee on Core Health and Disability Support Services (1993)
6.
go back to reference Nord, E.: Severity of illness versus expected benefit in societal evaluation of healthcare interventions. Exp. Rev. Pharmacoecon. Outcomes Res. 1, 85–92 (2001)CrossRef Nord, E.: Severity of illness versus expected benefit in societal evaluation of healthcare interventions. Exp. Rev. Pharmacoecon. Outcomes Res. 1, 85–92 (2001)CrossRef
7.
go back to reference Dolan, P., Shaw, R., Tsuchiya, A., Williams, A.: QALY-maximisation and people’s preferences: a methodological review of the literature. Health Econ. 14, 197–208 (2005)CrossRefPubMed Dolan, P., Shaw, R., Tsuchiya, A., Williams, A.: QALY-maximisation and people’s preferences: a methodological review of the literature. Health Econ. 14, 197–208 (2005)CrossRefPubMed
8.
go back to reference Shah, K.: Severity of illness and priority setting in health care: a review of the literature. Health Policy 93, 77–84 (2009)CrossRefPubMed Shah, K.: Severity of illness and priority setting in health care: a review of the literature. Health Policy 93, 77–84 (2009)CrossRefPubMed
9.
go back to reference Norwegian Medicine Agency. Guidelines for pharmacoeconomic evaluations. Oslo (2002) Norwegian Medicine Agency. Guidelines for pharmacoeconomic evaluations. Oslo (2002)
10.
go back to reference Van de Wetering, E.J., Stolk, E.A., van Exel, N.J.A., Brouwer, W.B.F.: Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfall. Eur. J. Health Econ. 14, 107–115 (2013)CrossRefPubMedCentralPubMed Van de Wetering, E.J., Stolk, E.A., van Exel, N.J.A., Brouwer, W.B.F.: Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfall. Eur. J. Health Econ. 14, 107–115 (2013)CrossRefPubMedCentralPubMed
11.
go back to reference Department of Health.: A new value-based approach to the pricing of branded medicines. Government response to consultation. London (2011) Department of Health.: A new value-based approach to the pricing of branded medicines. Government response to consultation. London (2011)
12.
go back to reference Nord, E.: The trade-off between severity of illness and treatment effect in cost-value analysis of health care. Health Policy 24, 227–238 (1993)CrossRefPubMed Nord, E.: The trade-off between severity of illness and treatment effect in cost-value analysis of health care. Health Policy 24, 227–238 (1993)CrossRefPubMed
13.
go back to reference Nord, E.: Cost-value analysis in health care. Cambridge University Press, Cambridge (1999) Nord, E.: Cost-value analysis in health care. Cambridge University Press, Cambridge (1999)
14.
go back to reference Williams, A.: Ethics and efficiency in the provision of health care. In: Bell, J.M., Mendus, S. (eds.) Philosophy and medical welfare. Cambridge University Press, Cambridge (1988) Williams, A.: Ethics and efficiency in the provision of health care. In: Bell, J.M., Mendus, S. (eds.) Philosophy and medical welfare. Cambridge University Press, Cambridge (1988)
15.
go back to reference Williams, A.: Intergenerational equity: an exploration of the ‘fair innings’ argument. Health Econ. 6, 117–132 (1997)CrossRefPubMed Williams, A.: Intergenerational equity: an exploration of the ‘fair innings’ argument. Health Econ. 6, 117–132 (1997)CrossRefPubMed
16.
go back to reference Nord, E., Johansen, R.: Concerns for severity in priority setting in health care: A review of trade-off data in preference studies and implications for societal willingness to pay for a QALY. Health Policy. doi:10.1016/j.healthpol.2014.02.009 (2014) Nord, E., Johansen, R.: Concerns for severity in priority setting in health care: A review of trade-off data in preference studies and implications for societal willingness to pay for a QALY. Health Policy. doi:10.​1016/​j.​healthpol.​2014.​02.​009 (2014)
17.
go back to reference Nord, E., Pinto, J.L., Richardson, J., Menzel, P., Ubel, P.: Incorporating societal concerns for fairness in numerical valuations of health programs. Health Econ. 8, 25–39 (1999)CrossRefPubMed Nord, E., Pinto, J.L., Richardson, J., Menzel, P., Ubel, P.: Incorporating societal concerns for fairness in numerical valuations of health programs. Health Econ. 8, 25–39 (1999)CrossRefPubMed
18.
go back to reference Elvik, R.: The validity of using health state indexes in measuring the consequences of traffic injury for public health. Soc. Sci. Med. 40, 1385–1398 (1995)CrossRefPubMed Elvik, R.: The validity of using health state indexes in measuring the consequences of traffic injury for public health. Soc. Sci. Med. 40, 1385–1398 (1995)CrossRefPubMed
19.
go back to reference Nord, E., Wisløff, F., Hjorth, M., Westin, J.: Cost-utility analysis of melphalan plus prednisone with or without interferon-α2b in newly diagnosed multiple myeloma. Pharmacoeconomics 12, 89–103 (1997)CrossRefPubMed Nord, E., Wisløff, F., Hjorth, M., Westin, J.: Cost-utility analysis of melphalan plus prednisone with or without interferon-α2b in newly diagnosed multiple myeloma. Pharmacoeconomics 12, 89–103 (1997)CrossRefPubMed
20.
go back to reference Nord, E., Dalgard, O.S.: Economic evaluation of course in coping with depression. J. Nor. Med. Assoc. 126, 586–588 (2006). (text in Norwegian) Nord, E., Dalgard, O.S.: Economic evaluation of course in coping with depression. J. Nor. Med. Assoc. 126, 586–588 (2006). (text in Norwegian)
21.
go back to reference Williams, A.: The measurement and valuation of health: a chronicle. Discussion paper 136. Centre for Health Economics. York: The University of York (1995) Williams, A.: The measurement and valuation of health: a chronicle. Discussion paper 136. Centre for Health Economics. York: The University of York (1995)
22.
go back to reference Dolan, P.: The measurement of individual utility and social welfare. J. Health Econ. 17, 39–52 (1998)CrossRefPubMed Dolan, P.: The measurement of individual utility and social welfare. J. Health Econ. 17, 39–52 (1998)CrossRefPubMed
23.
go back to reference Green, C., Gerard, K.: Exploring the social value of health care interventions: a stated preference discrete choice experiment. Health Econ. 18, 951–976 (2009)CrossRefPubMed Green, C., Gerard, K.: Exploring the social value of health care interventions: a stated preference discrete choice experiment. Health Econ. 18, 951–976 (2009)CrossRefPubMed
24.
go back to reference Dolan, P., Edlin, R., Tsuchyia, A., et al.: The relative value of health gains to different beneficiaries. Report to the NIHR and NICE (2008) Dolan, P., Edlin, R., Tsuchyia, A., et al.: The relative value of health gains to different beneficiaries. Report to the NIHR and NICE (2008)
25.
go back to reference Goldman, D., Lakdawalla, D., Philipson, T.J., Yin, W.: Valuing health technologies at NICE. Health Econ. 19, 1109–1116 (2010)CrossRefPubMed Goldman, D., Lakdawalla, D., Philipson, T.J., Yin, W.: Valuing health technologies at NICE. Health Econ. 19, 1109–1116 (2010)CrossRefPubMed
26.
go back to reference Nord, E.: The social value of a QALY: comments to the final report from the SVQ team. Note submitted to NICE. Oslo: Norwegian Institute of Public Health (2008) Nord, E.: The social value of a QALY: comments to the final report from the SVQ team. Note submitted to NICE. Oslo: Norwegian Institute of Public Health (2008)
27.
go back to reference Nord, E.: The validity of a visual analogue scale in determining social utility weights for health states. Int. J. Health Plan Manag. 6, 234–242 (1991)CrossRef Nord, E.: The validity of a visual analogue scale in determining social utility weights for health states. Int. J. Health Plan Manag. 6, 234–242 (1991)CrossRef
28.
go back to reference Nord, E., Richardson, J., Macarounas-Kirchman, K.: Societal evaluations of health states. Int. J. Technol. Assess. Health Care 9, 463–478 (1993)CrossRefPubMed Nord, E., Richardson, J., Macarounas-Kirchman, K.: Societal evaluations of health states. Int. J. Technol. Assess. Health Care 9, 463–478 (1993)CrossRefPubMed
29.
go back to reference Nord, E.: The person trade-off approach to valuing health care programs. Med. Dec. Making 15, 201–208 (1995)CrossRef Nord, E.: The person trade-off approach to valuing health care programs. Med. Dec. Making 15, 201–208 (1995)CrossRef
30.
go back to reference Ubel, P., Loewenstein, G., Scanlon, D., Kamlet, M.: Individual utilities are inconsistent with rationing choices. Med. Dec. Making 16, 108–116 (1996)CrossRef Ubel, P., Loewenstein, G., Scanlon, D., Kamlet, M.: Individual utilities are inconsistent with rationing choices. Med. Dec. Making 16, 108–116 (1996)CrossRef
31.
go back to reference Richardson, J.: Critique and some recent contributions to the theory of cost-utility analysis. Working paper 77. Melbourne: Centre for Health Program Evaluation (1997) Richardson, J.: Critique and some recent contributions to the theory of cost-utility analysis. Working paper 77. Melbourne: Centre for Health Program Evaluation (1997)
32.
go back to reference Pinto, J.L.P.: Is the person trade-off a valid method for allocating health care resources? Health Econ. 6, 71–81 (1997)CrossRef Pinto, J.L.P.: Is the person trade-off a valid method for allocating health care resources? Health Econ. 6, 71–81 (1997)CrossRef
33.
go back to reference Dolan, P., Green, C.: Using the person trade-off approach to examine differences between individual and social values. Health Econ. 7, 307–312 (1998)CrossRefPubMed Dolan, P., Green, C.: Using the person trade-off approach to examine differences between individual and social values. Health Econ. 7, 307–312 (1998)CrossRefPubMed
34.
go back to reference Schwarzinger, M., Stouthard, M., Burström, K., Nord, E., et al.: Cross national agreement on disability weights: the European disability weights project. Pop. Health Metrics 1, 9 (2003)CrossRef Schwarzinger, M., Stouthard, M., Burström, K., Nord, E., et al.: Cross national agreement on disability weights: the European disability weights project. Pop. Health Metrics 1, 9 (2003)CrossRef
35.
go back to reference Gyrd-Hansen, D.: Investigating the social value of health changes. J. Health Econ. 23, 1101–1116 (2004)CrossRefPubMed Gyrd-Hansen, D.: Investigating the social value of health changes. J. Health Econ. 23, 1101–1116 (2004)CrossRefPubMed
36.
go back to reference Dolan, P., Tsuchiya, A.: Health priorities and public preferences: the relative importance of past health experience and future health prospects. J. Health Econ. 24, 703–714 (2005)CrossRefPubMed Dolan, P., Tsuchiya, A.: Health priorities and public preferences: the relative importance of past health experience and future health prospects. J. Health Econ. 24, 703–714 (2005)CrossRefPubMed
37.
go back to reference Koopmanschap, M., Stolk, E., Koolman, X.: Dear policy maker: have you made up your mind? Int. J. Technol. Assess. Health Care 26, 198–204 (2010)CrossRefPubMed Koopmanschap, M., Stolk, E., Koolman, X.: Dear policy maker: have you made up your mind? Int. J. Technol. Assess. Health Care 26, 198–204 (2010)CrossRefPubMed
38.
go back to reference Lancsar, E., Wildman, J., Donaldson, C., Ryan, M., Baker, R.: Deriving distributional weights for QALYs through discrete choice experiments. J. Health Econ. 30, 466–478 (2011)CrossRefPubMed Lancsar, E., Wildman, J., Donaldson, C., Ryan, M., Baker, R.: Deriving distributional weights for QALYs through discrete choice experiments. J. Health Econ. 30, 466–478 (2011)CrossRefPubMed
39.
go back to reference Rosser, R., Kind, P.: A scale of valuations of health states: is there a social consensus? Int J Epidem 7, 347–358 (1978)CrossRef Rosser, R., Kind, P.: A scale of valuations of health states: is there a social consensus? Int J Epidem 7, 347–358 (1978)CrossRef
40.
go back to reference Nord, E.: Severity of illness and priority setting: worrisome lack of discussion of surprising finding. J. Health Econ. 25, 170–172 (2006)CrossRefPubMed Nord, E.: Severity of illness and priority setting: worrisome lack of discussion of surprising finding. J. Health Econ. 25, 170–172 (2006)CrossRefPubMed
41.
go back to reference Dolan, P., Tsuchyia, A.: Severity of illness and priority setting: worrisome criticism of inconvenient finding? J. Health Econ. 25, 173–174 (2006)CrossRef Dolan, P., Tsuchyia, A.: Severity of illness and priority setting: worrisome criticism of inconvenient finding? J. Health Econ. 25, 173–174 (2006)CrossRef
42.
go back to reference Rand-Hendriksen, K., Augestad, L., Dahl, F., Kristiansen, I.S., et al.: A shortcut to mean-based time tradeoff tariffs for the EQ-5D? Med. Dec. Making 32, 569–577 (2012)CrossRef Rand-Hendriksen, K., Augestad, L., Dahl, F., Kristiansen, I.S., et al.: A shortcut to mean-based time tradeoff tariffs for the EQ-5D? Med. Dec. Making 32, 569–577 (2012)CrossRef
43.
go back to reference Borge, O.M.: The use of health economics methods at the Norwegian Medicine Agency 2001–2009. Master degree dissertation. Oslo: University of Oslo (2011) Borge, O.M.: The use of health economics methods at the Norwegian Medicine Agency 2001–2009. Master degree dissertation. Oslo: University of Oslo (2011)
44.
go back to reference Dolan, P., Cookson, R.: Measuring preferences over the distribution of health benefits. University of York, Mimeo (1998) Dolan, P., Cookson, R.: Measuring preferences over the distribution of health benefits. University of York, Mimeo (1998)
45.
go back to reference Bleichrodt, H., Doctor, J., Stolk, E.: A nonparametric elicitation of the equity-efficiency trade-off in cost-utility analysis. J. Health Econ. 24, 655–678 (2005)CrossRefPubMed Bleichrodt, H., Doctor, J., Stolk, E.: A nonparametric elicitation of the equity-efficiency trade-off in cost-utility analysis. J. Health Econ. 24, 655–678 (2005)CrossRefPubMed
46.
go back to reference Ottersen, T.: Life time QALY prioritarianism in priority setting. J. Med. Ethics 39, 175–180 (2013)CrossRefPubMed Ottersen, T.: Life time QALY prioritarianism in priority setting. J. Med. Ethics 39, 175–180 (2013)CrossRefPubMed
47.
go back to reference Daniels, N.: Just health care. Cambridge University Press, Cambridge (1985)CrossRef Daniels, N.: Just health care. Cambridge University Press, Cambridge (1985)CrossRef
48.
Metadata
Title
Transforming EQ-5D utilities for use in cost–value analysis of health programs
Authors
Erik Nord
Rune Johansen
Publication date
01-04-2015
Publisher
Springer Berlin Heidelberg
Published in
The European Journal of Health Economics / Issue 3/2015
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-014-0576-6

Other articles of this Issue 3/2015

The European Journal of Health Economics 3/2015 Go to the issue